cardiovascular-disease-risk

Documents about cardiovascular-disease-risk

• Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway#889940ClinicalTrials.gov
• Impact of a Mediterranean Diet on Cardiovascular Disease Risk Factors#1410938ClinicalTrials.gov
• Interaction between genistein and the endothelial activation and stress index in relation to estimated 10-year atherosclerotic cardiovascular disease risk classification#469494PLOS
• The Longitudinal Evaluation of Ovarian Aging and Cardiovascular Risk#879365ClinicalTrials.gov
• Polygenic Risk Score for Optimizing Primary Prevention in Intermediate-Risk Populations#872632ClinicalTrials.gov
• Gestational Diabetes Mellitus and Implications for Cardiovascular Disease Risk#1463810ClinicalTrials.gov
• Coronary Computed Tomography Angiography In Rheumatoid Arthritis Study#1445452ClinicalTrials.gov
• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease#1365694ClinicalTrials.gov
• Feedback of Treatment Intensification Data to Reduce Cardiovascular Disease Risk (FIT)#966699ClinicalTrials.gov
• Stress Reactivity and Mother-Infant Cardiovascular Disease Risk#1321002ClinicalTrials.gov
• Osteoarthritis Cardiovascular Risk Factors#1085908ClinicalTrials.gov
• Breast Artery Calcification (BAC) and Female Cardiovascular Disease#1261844ClinicalTrials.gov
• Surveillance of Cardiovascular Risk Factors in Cameroonian Garrison#1230310ClinicalTrials.gov
• Interval Training and Electromagnetic Therapy on Cardiovascular Disease Risk in Diabetic Elderly#845133ClinicalTrials.gov
• Motivational Interviewing Effect on Reducing Cardiovascular Disease Risk Factors#918475ClinicalTrials.gov
• Prospective Assessment of Atherosclerotic Cardiovascular Disease (ASCVD) Risk#979722ClinicalTrials.gov
• Economic burden of pulmonary arterial hypertension in Switzerland#141260PLOS
• Seeing the invisible: Reorienting cardiovascular risk prediction across the disease trajectory#1416395PLOS
• Interstitial Lung Disease is a Risk Factor for Cardiovascular Disease#1212744ClinicalTrials.gov
• The principles of Population-Level Approaches to Dementia Risk Reduction (PLADRR)#141267PLOS
• Denver Health Cardiovascular Disease (CVD) Prevention Program#865440ClinicalTrials.gov
• Effects of Health Promoting Programs on Cardiovascular Disease Risk#407800ClinicalTrials.gov
• Study on Nutrition and Cardiovascular Risk in Spain.#1419239ClinicalTrials.gov
• Impact of Hibiscus on Cardiovascular Disease Risk#125959ClinicalTrials.gov
• Bromelain and Cardiovascular Risk Factors in Diabetes#261414ClinicalTrials.gov
• Maternal congenital heart disease: Implications for the next generation#409733PLOS
• Cardiovascular Risk Factors in Coeliac Disease: a Series of Studies#832250ClinicalTrials.gov
• Risk Factors for Acquired Cardiovascular Disease in Adults With Congenital Heart Disease#850263ClinicalTrials.gov
• Cardiovascular Disease Awareness in Rheumatoid Arthritis and Knee Osteoarthritis#1102794ClinicalTrials.gov
• Association of Multiple CardiOvascular Risk Factors and Erectile Function Across Europe#1464096ClinicalTrials.gov
• General practice interventions to reduce cardiovascular disease risk in patients with severe mental illness: A scoping review#180459PLOS
• Predicting lifetime cardiovascular risk and benefits of preventive treatment in patients with established atherosclerotic cardiovascular disease: the SMART-REACH2 model#264625Apollo
• Prevention of Cardiovascular Disease With Med or Veg Diets#1446149ClinicalTrials.gov
• The impact of climate change on human health and pharmaceuticals#1148176PLOS
• LDL-C target attainment and treatment costs in high-risk and very-high-risk patients with or without bempedoic acid: A Spanish cohort simulation#455616PLOS
• Cardiovascular Patients With no Standard Modifiable Risk Factors#1476129ClinicalTrials.gov
• Cardiovascular Profiles in Rheumatoid Arthritis#1321322ClinicalTrials.gov
• Cardiovascular Risk in Patients With IBD#803886ClinicalTrials.gov
• A Mediterranean Diet Nutrition Education Program for the Reduction of Cardiovascular Disease Risk in the Southeastern U.S.#804228ClinicalTrials.gov
• Interactive Cholesterol Advisory Tool#902726ClinicalTrials.gov
• Cardiovascular Risk Evaluation and Antiretrovirals in HIV#1463138ClinicalTrials.gov
• Plasma proteomic signatures of subclinical atherosclerosis progression for cardiovascular risk stratification: A cohort study#1404924PLOS
• Effects of Cocoa Products on Cardiovascular Disease Risk Factors#800578ClinicalTrials.gov
• Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support#981898ClinicalTrials.gov
• Alirocumab and Ischemic Risk in Atherosclerotic Cardiovascular Disease (ASCVD)#1371037ClinicalTrials.gov
• Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease#917461ClinicalTrials.gov
• Pomegranate Supplementation on Physical Function and Cardiovascular Disease Risk in CKD Patients#1033045ClinicalTrials.gov
• Feasibility of Reducing Cardiovascular Disease Risk Factors in Hispanics Through a Family-Based Community Intervention#1381698ClinicalTrials.gov
• Machine learning–driven integration of 24-hour ambulatory blood pressure and its variability#376026PLOS
• The Association of SAA With Apolipoprotein B Affects Cardiovascular Risk#249526ClinicalTrials.gov